What are the contraindications for mechanical thrombectomy in patients with severe stroke symptoms, such as high National Institutes of Health Stroke Scale (NIHSS) scores, large infarct cores, bleeding disorders, or significant pre-stroke disability?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraindications for Mechanical Thrombectomy

Mechanical thrombectomy has very few absolute contraindications, and current guidelines emphasize expanding access rather than restricting it—the primary barriers are technical feasibility and time windows rather than patient-specific contraindications. 1

Absolute Contraindications

The following represent true contraindications where mechanical thrombectomy should not be performed:

  • No large vessel occlusion on angiography - Mechanical thrombectomy requires a documented causative occlusion of the internal carotid artery (ICA) or middle cerebral artery (MCA) M1 segment on non-invasive angiography (CTA) 1
  • Absence of salvageable brain tissue - Patients with ASPECTS <6 in the early window (0-6 hours) should not undergo thrombectomy 1
  • Lack of appropriate mismatch in extended window - Beyond 6 hours, patients must demonstrate sizable mismatch between ischemic core and hypoperfusion area per DAWN or DEFUSE-3 criteria 1, 2

Relative Contraindications (Not Absolute Barriers)

Clinical Factors That Are NOT Contraindications

Importantly, several factors that clinicians might consider contraindications are actually not barriers to thrombectomy:

  • Low NIHSS scores (<6) - While guidelines recommend NIHSS ≥6, research demonstrates mechanical thrombectomy is safe and effective in patients with NIHSS <6 and large vessel occlusions, with decreased mortality and smaller infarct size 3, 4
  • High NIHSS scores - Severe strokes (NIHSS >25-30) are not contraindications; these patients may benefit most from intervention 5
  • Advanced age (>80 years) - Age alone should not be an exclusion criterion, as elderly patients comprise the majority of stroke victims and may still benefit 5
  • Pre-stroke disability (mRS >1) - While guidelines specify mRS 0-1 for standard eligibility, this reflects trial populations rather than absolute contraindications 1

Medical Comorbidities That Are NOT Contraindications

  • Contraindications to IV thrombolysis - Patients with bleeding disorders, recent surgery, or other contraindications to IV tPA can safely undergo primary mechanical thrombectomy 6
  • Anticoagulation use - Therapeutic anticoagulation is not a contraindication to mechanical thrombectomy, though it may preclude concurrent IV tPA 6

Time-Based Restrictions

  • Beyond 24 hours from last known well - No guideline support exists for thrombectomy beyond 24 hours in anterior circulation strokes 1
  • 0-6 hours window - Requires ASPECTS ≥6, NIHSS ≥6, confirmed large vessel occlusion, and age ≥18 years 1
  • 6-16 hours window - Must meet DAWN or DEFUSE-3 eligibility criteria with advanced perfusion imaging demonstrating salvageable tissue 1, 2
  • 16-24 hours window - Only reasonable if meeting DAWN criteria specifically 1

Technical and Facility Requirements

  • Lack of experienced stroke center - Treatment requires immediate access to cerebral angiography and qualified interventionalists with proper credentialing 1
  • Inability to achieve safe vascular access - Any condition making angiography technically impossible represents a contraindication 5

Important Caveats

The 2012 CHEST guidelines suggested against mechanical thrombectomy (Grade 2C), but this recommendation is obsolete 5. Current 2025 American Heart Association guidelines strongly support mechanical thrombectomy based on overwhelming evidence from multiple randomized trials 1.

Uncompensated hypertension (systolic >180 mmHg or diastolic >100 mmHg on three repeated measures) was listed as a contraindication in older trial design standards 5, but modern practice focuses on blood pressure management rather than exclusion, particularly for mechanical thrombectomy without concurrent IV tPA.

The presence of IV tPA contraindications should never delay or prevent mechanical thrombectomy - these patients can safely undergo primary mechanical thrombectomy with similar recanalization rates and acceptable safety profiles 6.

References

Guideline

Criteria for Thrombectomy in Acute Ischemic Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Imaging Selection for Mechanical Thrombectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mechanical Thrombectomy in Patients Presenting with NIHSS Score <6: A Safety and Efficacy Analysis.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the indication for mechanical thrombectomy based on the National Institutes of Health Stroke Scale (NIHSS) score?
What is the assessment and plan for a patient with an ischemic stroke found to have a left M1 (middle cerebral artery) occlusion status post (after) thrombectomy?
What are the benefits of delayed thrombectomy in patients with thrombosis?
What are the contraindications for mechanical thrombectomy?
What is the next step in therapy for a patient presenting with symptoms of a stroke, last seen normal 5 hours ago, with a large vessel occlusion in an M1 distribution, no hemorrhage on CT brain scan, normal glucose, hypertension, and an National Institutes of Health Stroke Scale (NIHSS) score of 8?
What is Semmorilin?
What is the management plan for a patient with left anterior hemiblock (LAH), with or without a history of cardiovascular disease, hypertension, or other risk factors?
What is the recommended dosage of Alteplase (tissue plasminogen activator) for thrombolysis in a patient with acute ischemic stroke?
What's the next step for rate control in an elderly patient with atrial fibrillation (AFib) and rapid ventricular response (RVR), currently on metoprolol (Toprol) 50mg twice daily (BID), with marginal systolic blood pressure (SBP) and potential hypotension?
What is the proper titration protocol for carvedilol (beta blocker) in patients with heart failure or hypertension, considering factors such as renal function and potential adverse effects?
Does growth hormone (GH) naturally decrease with age?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.